Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PE P-20:3/22:4)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST003629 AN005962 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST002452 AN004007 Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations Brain Human Dementia University of Sydney LC-MS
  logo